Efficacy and safety of long-term, open-label treatment of calcitriol in postmenopausal osteoporosis: A retrospective analysis

Current Therapeutic Research - Clinical and Experimental

Volumn 57, Issue 11, 1996, Pages 857-868

  Caniggia, Angelo ^a   Nuti, Ranuccio ^a   Martini, Giuseppe ^a   Frediani, Bruno ^a   Giovani, Silvia ^a   Valenti, Roberto ^a   Silvestri, Giovanna ^a   Matarazzo, Maddalena ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; CREATININE; HYDROXYPROLINE; UREA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BODY HEIGHT; BONE DENSITY; BONE PAIN; CALCIUM ABSORPTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FRACTURE; HUMAN; INTESTINE ABSORPTION; LONG TERM CARE; MAJOR CLINICAL STUDY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URINARY EXCRETION;

EID: 0029949649     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(96)80019-1     Document Type: Article

References (25)

1. Riggs BL, Melton LJ III. Involutional osteoporosis. NEJM. 1986;314:1676-1686.
2. Caniggia A, Gennari C, Bianchi V, Guideri R. Intestinal absorption of 45Ca in senile osteoporosis. Acta Med Scand. 1963;173:613-617.
3. Reichel H, Koeffler HP, Norman AW. The role of the vitamin D endocrine system in healthy and diseased subjects. NEJM. 1989;320:980-991.
4. Caniggia A, Loré F, Di Cairano G, Nuti R. Main endocrine modulators of vitamin D hydroxylase in human pathophysiology. J Steroid Biochem Mol Biol. 1987;27:815-824.
5. Gallagher JC, Riggs BL, De Luca HF. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol. 1980;51:1359-1364.
6. Gallagher JC, Riggs BL, Eisman J, et al. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: Effect of age and dietary calcium. J Clin Invest. 1979;64:729-736.
7. Lund B, Sorensen OH, Lund B, Agner E. Serum 1,25-dihydroxyvitamin D in normal subjects and in patients with postmenopausal osteopenia. Influence of age, renal function and oestrogen therapy. Horm Metab Res. 1982;14:271-274.
8. Caniggia A, Vattimo A. Effects of 1,25 dihydroxycholecalciferol on calcium absorption in postmenopausal osteoporosis. Clin Endocrinol. 1979;11:99-103.
9. Gallagher JC. Pathogenesis of postmenopausal osteoporosis: The role of calcitriol therapy. In: Christiansen C, Riis B, eds. Osteoporosis: Proceedings 1993. 1993:538-539.
10. 3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis. Eur J Clin Invest. 1981;11:305-309.
11. 3 on biochemical indices of bone turnover in post-menopausal women. Acta Med Scand. 1984;215:411-415.
12. Caniggia A, Nuti R, Loré F, et al. Long-term treatment with calcitriol in postmenopausal osteoporosis. Metabolism. 1990;39:43-49.
13. Gallagher JC, Goldgar D. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. Ann Intern Med. 1990;113:649-655.
14. Tilyard MW, George CB, Spears GFS, et al. Treatment of postmenopausal osteoporosis with calcitriol or calcium. NEJM. 1992;326:357-362.
15. Van Kuijk C, Genant HK. Radiological aspects. In: Riggs BL, Melton LJ III, eds. Osteoporosis: Etiology, Diagnosis, and Management. Philadelphia: Lippincott-Raven Publisher; 1995:249-273.
16. Nuti R, Martini G. Measurements of bone mineral density of DXA total body absorptiometry in different skeletal sites in postmenopausal osteoporosis. Bone. 1992;13:173-178.
17. Nuti R, Martini G, Frediani B, et al. Effect of alcohol abuse on bone metabolism. Eur J Exp Musculoskelet Res. 1992;1:81-85.
18. Nuti R. Malattie da guasti del metabolismo osse. In: Coppo M, Gibertini P, eds. Dizionario delle Analisi e Ricerche Cliniche D'uso Corrente. Padova: Piccin Editore; 1991:746-775.
19. Nuti R, Martini G, Righi G, et al. Comparison of total body measurements by dual-energy x-ray absorptiometry and dual-photon absorptiometry. J Bone Miner Res. 1991;6:681-687.
20. Kotowicz MA, Melton LJ III, Cedel SL, et al. Effect of age on variables relating to calcium and phosphorus metabolism in women. J Bone Miner Res. 1990;5:345-352.
21. Curham GC, Willett WC, Rimm LEB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. NEJM. 1993;328:833-838.
22. Borghi L, Ferretti PP, Elia GF, et al. Epidemiological study of urinary tract stones in a northern Italian city. Br J Urol. 1990;65:231-235.
23. Caniggia A, Nuti R, Loré F, et al. Long term calcitriol treatment in postmenopausal osteoporosis: Follow-up in two hundred patients. In: Norman AW, Schaefer R, Grigoleit HG, et al, eds. Vitamin D: Molecular, Cellular and Clinical Endocrinology. New York: De Gruyter; 1988:807-816.
24. Griffin J. Osteoporosis and the Risk of Fracture. London: Office of Health Economics, 1990.
25. Aloia JF, Vaswani A, Yeh JK, et al. Calcitriol in the treatment of post-menopausal osteoporosis. Am J Med. 1988;84:401-408.